Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease
-
Published:2024-06-20
Issue:6
Volume:13
Page:751
-
ISSN:2076-3921
-
Container-title:Antioxidants
-
language:en
-
Short-container-title:Antioxidants
Author:
Lee On Ying Angela1, Wong Alex Ngai Nick1ORCID, Ho Ching Yan1, Tse Ka Wai1, Chan Angela Zaneta2, Leung George Pak-Heng3ORCID, Kwan Yiu Wa4, Yeung Martin Ho Yin12ORCID
Affiliation:
1. Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China 2. Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China 3. Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China 4. The School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China
Abstract
Chronic kidney disease (CKD) presents a substantial global public health challenge, with high morbidity and mortality. CKD patients often experience dyslipidaemia and poor glycaemic control, further exacerbating inflammation and oxidative stress in the kidney. If left untreated, these metabolic symptoms can progress to end-stage renal disease, necessitating long-term dialysis or kidney transplantation. Alleviating inflammation responses has become the standard approach in CKD management. Medications such as statins, metformin, and GLP-1 agonists, initially developed for treating metabolic dysregulation, demonstrate promising renal therapeutic benefits. The rising popularity of herbal remedies and supplements, perceived as natural antioxidants, has spurred investigations into their potential efficacy. Notably, lactoferrin, Boerhaavia diffusa, Amauroderma rugosum, and Ganoderma lucidum are known for their anti-inflammatory and antioxidant properties and may support kidney function preservation. However, the mechanisms underlying the effectiveness of Western medications and herbal remedies in alleviating inflammation and oxidative stress occurring in renal dysfunction are not completely known. This review aims to provide a comprehensive overview of CKD treatment strategies and renal function preservation and critically discusses the existing literature’s limitations whilst offering insight into the potential antioxidant effects of these interventions. This could provide a useful guide for future clinical trials and facilitate the development of effective treatment strategies for kidney functions.
Funder
This study was supported by Departmental Start-up Fund for M.H.Y.Y. from The Hong Kong Polytechnic University.
Reference291 articles.
1. Francis, A., Harhay, M.N., Ong, A.C.M., Tummalapalli, S.L., Ortiz, A., Fogo, A.B., Fliser, D., Roy-Chaudhury, P., Fontana, M., and Nangaku, M. (2024). Chronic kidney disease and the global public health agenda: An international consensus. Nat. Rev. Nephrol., 1–13. 2. American Diabetes Association Professional Practice Committee (2022). Addendum. 11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1): S175–S184. Diabetes Care, 45, 2182–2184. 3. Vaidya, S.R., and Aeddula, N.R. (2024). Chronic Kidney Disease. StatPearls, StatPearls Publishing. 4. Chronic Kidney Disease Diagnosis and Management: A Review;Chen;JAMA,2019 5. GBD Chronic Kidney Disease Collaboration (2020). Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 395, 709–733.
|
|